218 related articles for article (PubMed ID: 29846838)
21. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes).
Kaliki S; Patel A; Iram S; Ramappa G; Mohamed A; Palkonda VAR
Retina; 2019 Feb; 39(2):379-391. PubMed ID: 29210937
[TBL] [Abstract][Full Text] [Related]
22. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
23. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
24. Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.
Amram AL; Rico G; Kim JW; Chintagumpala M; Herzog CE; Gombos DS; Chévez-Barrios P
Ophthalmology; 2017 Oct; 124(10):1540-1547. PubMed ID: 28528011
[TBL] [Abstract][Full Text] [Related]
25. Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients.
Kaliki S; Mittal P; Mohan S; Chattannavar G; Jajapuram SD; Mohamed A; Palkonda VAR
Eye (Lond); 2019 Aug; 33(8):1297-1304. PubMed ID: 30932036
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of 58 children with retinoblastoma.
Mathew L; Miale TD; Rao S; Lobel SA; Fishman GA; Goldberg MF
Ophthalmic Paediatr Genet; 1984 Aug; 4(2):67-74. PubMed ID: 6545386
[TBL] [Abstract][Full Text] [Related]
27. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma.
Abramson DH; Beaverson KL; Chang ST; Dunkel IJ; McCormick B
Arch Ophthalmol; 2004 Sep; 122(9):1316-23. PubMed ID: 15364710
[TBL] [Abstract][Full Text] [Related]
28. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
29. Retinoblastoma.
Ortiz MV; Dunkel IJ
J Child Neurol; 2016 Feb; 31(2):227-36. PubMed ID: 26023180
[TBL] [Abstract][Full Text] [Related]
30. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival.
Abramson DH; Beaverson K; Sangani P; Vora RA; Lee TC; Hochberg HM; Kirszrot J; Ranjithan M
Pediatrics; 2003 Dec; 112(6 Pt 1):1248-55. PubMed ID: 14654593
[TBL] [Abstract][Full Text] [Related]
31. Clinical course of retinoblastoma.
Islam F; Zafar SN; Siddiqui SN; Khan A
J Coll Physicians Surg Pak; 2013 Aug; 23(8):566-9. PubMed ID: 23930873
[TBL] [Abstract][Full Text] [Related]
32. Tumour size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effects on rates of globe salvage and high-risk histopathologic features.
Kim JW; Shah SN; Green S; O'Fee J; Tamrazi B; Berry JL
Acta Ophthalmol; 2020 Feb; 98(1):e121-e125. PubMed ID: 31421017
[TBL] [Abstract][Full Text] [Related]
33. [Intraocular retinoblastoma: new therapeutic options].
Imhof SM; Moll AC; Schouten-van Meeteren AY
Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2165-70. PubMed ID: 11727614
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
35. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
36. [Multidisciplinary management of retinoblastoma: Experience in 37 eyes].
Ossandón D; Zanolli M; Pérez V; Rojas T; Quijarro P; Kabalan P; Alvarez D; Varas M
Arch Soc Esp Oftalmol; 2015 Feb; 90(2):55-62. PubMed ID: 25617906
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
38. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
[TBL] [Abstract][Full Text] [Related]
39. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands.
Imhof SM; Moll AC; Schouten-van Meeteren AY
Br J Ophthalmol; 2006 Jul; 90(7):875-8. PubMed ID: 16613925
[TBL] [Abstract][Full Text] [Related]
40. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
